ESC 365 - Rate lowering and anti-arrhythmic drugs as monotherapy or dual therapy on the risk of pacemaker implantation in patients with atrial fibrillation

EHRA Premium Access

Rate lowering and anti-arrhythmic drugs as monotherapy or dual therapy on the risk of pacemaker implantation in patients with atrial fibrillation

Session: Young EP Poster Session - Young meets Experienced

Topic: Antiarrhythmic Drug Treatment

Speaker: Doctor F. Dalgaard (Gentofte, DK)

Event: EHRA 2018

Congress Presentation

Add to my library

About the speaker

Doctor Frederik Dalgaard

Gentofte University Hospital, Gentofte (Denmark)

0 follower

16 more presentations in this session

Poster discussant

Incidence of pulmonary vein conduction recovery after a 2-minute cryoballoon freeze for pulmonary vein isolation

Speaker: Doctor A. Pott (Ulm, DE)

Role of the late sodium current in determining electrophysiological characteristics of cardiac ventricular myocytes

Speaker: Doctor B. Horvath (Debrecen, HU)

Validation of a novel computer model of endo-epicardial electrical dissociation and transmural conduction during atrial fibrillation

Speaker: Doctor A. Gharaviri (Lugano, CH)

Augmented contractile remodeling is associated with increased susceptibility to drug-induced torsade de pointes arrhythmias in the chronic AV-block dog model

Speaker: Mr D. Sprenkeler (Utrecht, NL)

Access the full session

Young EP Poster Session - Young meets Experienced

Speakers: Doctor F. Dalgaard, Doctor A. Pott, Doctor B. Horvath, Doctor A. Gharaviri, Mr D. Sprenkeler

About the event

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources